ABSTRACT PURPOSE: To describe the clinical stages and management of Achromobacter xylosoxidans keratitis with post-LASIK epithelial ingrowth in two patients.
RESULTS: Both patients had been treated with topical antibiotics and corticosteroids for several weeks prior to presentation. Examination at presentation revealed significant areas of epithelial ingrowth without signs of acute inflammation, prompting an erroneous initial diagnosis of recurrent corneal erosion. A corneal infiltrate was eventually observed and A. xylosoxidans was cultured from both patients. Clinical resolution occurred with treatment consisting of topical fortified antibiotics. In one patient, the flap was lifted to obtain cultures and irrigate the stromal bed with fortified antibiotics.
CONCLUSIONS:
Post-LASIK epithelial ingrowth may have served as a risk factor for A. xylosoxidans infection. Classic signs of infectious keratitis were absent, delaying the diagnosis. Three clinical stages described herein may assist the clinician with diagnosis and customized management obviating the need for penetrating keratoplasty. A chromobacter xylosoxidans is a rare cause of post-LASIK keratitis. The two cases previously reported required penetrating keratoplasty for infection control. 1, 2 We successfully treated two patients with post-LASIK A. xylosoxidans keratitis associated with significant epithelial ingrowth, and believe the latter is an important risk factor for this infection. Our cases had clinical findings and outcomes that differed from those reported in the literature.
CASE REPORTS Case 1
A 46-year-old woman presented with a 6-week history of pain, tearing, and redness in her right eye. She had undergone LASIK 9 years prior with two enhancement procedures involving flap lift. She wore soft contact lenses for residual refractive error. Treatment included topical antibiotics (besifloxacin and levofloxacin) and corticosteroids without improvement.
At presentation, corrected distance visual acuity in her right eye was 20/80. Corneal examination revealed an area of epithelial ingrowth with the nasal third appearing to be liquefied epithelium ( Figure 1A) . There was no epithelial defect, infiltrate, diffuse lamellar keratitis, or anterior chamber inflammation. We suspected she had recurrent corneal erosion and added topical homatropine (5%). Corticosteroid was discontinued.
The following day she had increased pain. Examination showed 1+ stromal edema over the flap nasally and 1+ to 2+ cell in the anterior chamber. A diagnosis of keratouveitis was entertained and topical fluorometholone 0.1% three times a day was added.
One week later she reported no improvement. Examination showed a well-defined infiltrate with an overlying 2 3 2 mm epithelial defect ( Figure 1B) . Subsequently, the flap was lifted, epithelial ingrowth was removed, and the interface was scraped for cultures. Moxifloxacin 0.5%, fortified ceftazidime (50 mg/mL), and tobramycin (15 mg/mL) were used to irrigate the interface. The above-mentioned topical fortified antibiotics were administered every 2 hours.
Cultures grew A. xylosoxidans with accompanying antibiotic susceptibilities ( Table 1) . The pain had improved 3 days later, but corrected distance visual acuity was 20/300. Examination revealed a healed epithelial defect and resolving infiltrate, but 2+ diffuse lamellar keratitis was present. Systemic prednisone (80 mg daily) was added and the diffuse lamellar keratitis resolved. The corneal infiltrate fully resolved and she remains asymptomatic 1 year later with corrected distance visual acuity of 20/25 ( Figure 1C) .
Case 2
A 56-year-old woman presented with a 3-week history of pain, tearing, and redness in her right eye. She had undergone LASIK 8 years prior with two subsequent enhancements involving flap lift. She used a soft contact lens in her right eye. She had been treated with topical moxifloxacin and corticosteroids without relief.
Her corrected distance visual acuity was 20/40 in the right eye. Examination revealed extensive epithelial ingrowth peripherally and a small temporal ero-sion at the flap edge without infiltrate (Figure 2A) . She was diagnosed as having recurrent corneal erosion. Antibiotics were stopped, corticosteroids were tapered, and topical hypertonic saline was added.
She returned 2 weeks later with worsening symptoms. Few inflammatory cells were seen adjacent to the area of previous erosion with 2+ anterior chamber cell. Topical gatifloxacin 0.5% hourly and prednisolone acetate 1% three times a day were added. After signs and symptoms had improved, both drops were discontinued.
She returned 4 weeks later with worsening pain and redness in her right eye. Examination revealed a corneal infiltrate with adjacent keratolysis near the temporal edge of the flap. There was no diffuse lamellar keratitis, but the ingrowth had a liquefied appearance. There was also 1+ anterior chamber cell with 0.5-mm hypopyon ( Figure 2B) . The infiltrate was scraped for culture and she was prescribed hourly fortified vancomycin (25 mg/mL) and tobramycin (15 mg/mL). Cultures grew A. xylosoxidans with intermediate sensitivity to tobramycin ( Table 2) . Over a 4-week period, there was complete resolution of the infiltrate. She remains asymptomatic 1 year after presentation with corrected distance visual acuity of 20/20 -3 ( Figure 2C ). We recommended flap lift with antibiotic irrigation based on susceptibilities to remove epithelial ingrowth but she refused. 1 Del Valle and Font described a patient with A. xylosoxidans keratitis 2 years after LASIK. 2 In both reports, the infection was resistant to medical therapy and eventually required penetrating keratoplasty.
Epithelial ingrowth is not uncommon after LASIK enhancement. Areas of ingrowth are frequently associated with an area near the flap edge where the epithelial seal is not tight. This ingrowth may provide a potential track for surface organisms to gain access to the interface and corneal stroma. 3 Epithelial ingrowth was present in both of our patients.
We noted a progressive clinical presentation of the disease process. In stage I, patients presented with pain and redness in the setting of epithelial ingrowth without corneal inflammation. In stage II, the pain intensified and was associated with mild iridocyclitis. A key clinical sign at this stage was that the epithelial ingrowth appeared liquefied. In stage III, an infiltrate with overlying epithelial defect was seen and the above symptoms intensified.
A. xylosoxidans is an aerobic, non-fermenting Gram-negative bacterium with similarities to Pseudomonas. It has unique peritrichous flagella that confer increased mobility, allowing it to overcome host defense mechanisms. 4 These flagellae may facilitate the organism's ingress into the interface from an area of epithelial breakdown at the flap edge. It has also been reported that A. xylosoxidans can cause systemic infections in immunocompromised hosts. 5 Our patients Achromobacter Keratitis/Riaz et al were initially treated with topical steroids, so it is possible that this created a local immunocompromised milieu that facilitated propagation of infection.
A. xylosoxidans secretes an extracellular polymer biofilm that may result in its not eliciting a vigorous immune response until late in the course of infection. This biofilm may also confer increased resistance to antibiotics. Susceptibility studies have shown a trend for first-generation fluoroquinolones being more effective than third-and fourth-generation fluoroquinolones. 5 There has also been a report of successful treatment with polymyxin B/trimethoprim. 6 A. xylosoxidans isolated from our patients was sensitive to tobramycin and responded favorably to the chosen antibiotic therapy (Tables 1-2) .
Both of our patients wore soft contact lenses and A. xylosoxidans has been reported to have a propensity for causing infection in such patients. 7 Hypoxia from soft contact lens wear leads to increased lactic acid in the corneal epithelium and increased chance of epithelial defects due to glycogen insufficiency, which in turn favors an environment for infection. 7 The biofilm produced by A. xylosoxidans may also aggregate on the surface of the contact lens and storage case, making the organism more resistant to disinfection methods. 8 Post-LASIK epithelial ingrowth may potentiate A. xylosoxidans keratitis. The clinical management can be challenging due to the absence of classic clinical signs of infection. Awareness of the clinical stages of infection described herein may be helpful. A high index of suspicion of this organism should be held in patients with ingrowth after LASIK who present with recurrent erosion-like symptoms, especially if soft contact lens wear is noted. We recommend early flap lift to remove ingrowth and culture if infection is suspected. Identification of the organism permits targeted treatment and successful management of A. xylosoxidans keratitis.
